2013, Shohan., ISBN 4130461095, xvi, 322
Book
1980, 217
Book
Journal of the American Heart Association, ISSN 2047-9980, 10/2016, Volume 5, Issue 10, p. n/a
Background The extent to which angina is associated with future cardiovascular events in patients with coronary artery disease has long been debated. Methods...
cardiovascular events | coronary artery disease | angina | Cardiovascular events | Coronary artery disease | Angina | CARDIAC & CARDIOVASCULAR SYSTEMS | OUTPATIENTS | MYOCARDIAL-ISCHEMIA | RISK | SYMPTOMS | RATES | HEART-DISEASE | SOUL | PECTORIS | CLARIFY REGISTRY | CLINICAL-OUTCOMES | United States - epidemiology | Myocardial Infarction - epidemiology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Case-Control Studies | Myocardial Revascularization - utilization | Angina, Stable - epidemiology | Cardiovascular Diseases - mortality | Female | Registries | Stroke - epidemiology | Aged | Coronary Artery Disease - epidemiology | Odds Ratio | Heart Failure - epidemiology
cardiovascular events | coronary artery disease | angina | Cardiovascular events | Coronary artery disease | Angina | CARDIAC & CARDIOVASCULAR SYSTEMS | OUTPATIENTS | MYOCARDIAL-ISCHEMIA | RISK | SYMPTOMS | RATES | HEART-DISEASE | SOUL | PECTORIS | CLARIFY REGISTRY | CLINICAL-OUTCOMES | United States - epidemiology | Myocardial Infarction - epidemiology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Case-Control Studies | Myocardial Revascularization - utilization | Angina, Stable - epidemiology | Cardiovascular Diseases - mortality | Female | Registries | Stroke - epidemiology | Aged | Coronary Artery Disease - epidemiology | Odds Ratio | Heart Failure - epidemiology
Journal Article
Gastric Cancer, ISSN 1436-3291, 2019, pp. 1 - 8
A multidisciplinary approach based on guidelines and pathological diagnosis by specialized pathologists are important for improving the prognosis and QoL of...
Multidisciplinary board | Pathological diagnosis | Adjuvant therapy | Gastrointestinal stromal tumor | Guidelines | Pathology | Imatinib | Genotyping | Risk groups | Mitosis | Diagnosis | Multivariate analysis | Stomach cancer | Tumors
Multidisciplinary board | Pathological diagnosis | Adjuvant therapy | Gastrointestinal stromal tumor | Guidelines | Pathology | Imatinib | Genotyping | Risk groups | Mitosis | Diagnosis | Multivariate analysis | Stomach cancer | Tumors
Journal Article
Journal of Endourology, ISSN 0892-7790, 11/2011, Volume 25, Issue S1, pp. P1 - A373
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 2015, Volume 21, Issue 9, pp. 623 - 633
Abstract To investigate antimicrobial susceptibility patterns of various bacterial pathogens isolated from complicated urinary tract infection (UTI) cases, the...
Hematology, Oncology and Palliative Medicine | Surveillance | Susceptibility | Complicated urinary tract infection | INFECTIOUS DISEASES | RISK-FACTORS | METAANALYSIS | ACUTE UNCOMPLICATED CYSTITIS | PYELONEPHRITIS | MINIMUM INHIBITORY CONCENTRATION | STAPHYLOCOCCUS-AUREUS INFECTIONS | RESISTANT ESCHERICHIA-COLI | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | OUTCOMES | ASSOCIATION | Enterococcus faecalis - drug effects | Klebsiella pneumoniae - drug effects | Serratia marcescens - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Male | Microbial Sensitivity Tests | Drug Resistance, Multiple, Bacterial | Vancomycin - pharmacology | Linezolid - pharmacology | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Ampicillin - pharmacology | Klebsiella oxytoca - drug effects | Japan | Methicillin-Resistant Staphylococcus aureus - drug effects | Ciprofloxacin - pharmacology | Pseudomonas aeruginosa - drug effects | Amikacin - pharmacology | Imipenem - pharmacology | Gram-Negative Bacteria - drug effects | Fluoroquinolones - pharmacology | Aged | Anti-Bacterial Agents - pharmacology | Population Surveillance | Proteus mirabilis - drug effects
Hematology, Oncology and Palliative Medicine | Surveillance | Susceptibility | Complicated urinary tract infection | INFECTIOUS DISEASES | RISK-FACTORS | METAANALYSIS | ACUTE UNCOMPLICATED CYSTITIS | PYELONEPHRITIS | MINIMUM INHIBITORY CONCENTRATION | STAPHYLOCOCCUS-AUREUS INFECTIONS | RESISTANT ESCHERICHIA-COLI | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | OUTCOMES | ASSOCIATION | Enterococcus faecalis - drug effects | Klebsiella pneumoniae - drug effects | Serratia marcescens - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Male | Microbial Sensitivity Tests | Drug Resistance, Multiple, Bacterial | Vancomycin - pharmacology | Linezolid - pharmacology | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Ampicillin - pharmacology | Klebsiella oxytoca - drug effects | Japan | Methicillin-Resistant Staphylococcus aureus - drug effects | Ciprofloxacin - pharmacology | Pseudomonas aeruginosa - drug effects | Amikacin - pharmacology | Imipenem - pharmacology | Gram-Negative Bacteria - drug effects | Fluoroquinolones - pharmacology | Aged | Anti-Bacterial Agents - pharmacology | Population Surveillance | Proteus mirabilis - drug effects
Journal Article
2012, Shohan., ISBN 4772231463, x, 242
Book
1987, ISBN 0387171266, xi, 329
Book
Journal of Endourology, ISSN 0892-7790, 09/2014, Volume 28, Issue S1, pp. P1 - A316
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2012, Volume 5, Issue 6, pp. 748 - 755
Background-Although balloon pulmonary angioplasty (BPA) for inoperable patients with chronic thromboembolic pulmonary hypertension was first reported over a...
Peripheral vascular disease | Reperfusion | Pulmonary hypertension | Revascularization | EMBOLISM | revascularization | CARDIAC & CARDIOVASCULAR SYSTEMS | pulmonary hypertension | LUNG INJURY | reperfusion | peripheral vascular disease | INTERNATIONAL PROSPECTIVE REGISTRY | ENDARTERECTOMY | Reperfusion Injury - etiology | Hypertension, Pulmonary - diagnosis | Humans | Middle Aged | Ultrasonography, Interventional | Hypertension, Pulmonary - physiopathology | Male | Pulmonary Embolism - therapy | Pulmonary Artery - diagnostic imaging | Angioplasty, Balloon - adverse effects | Hypertension, Pulmonary - therapy | Recovery of Function | Cardiac Catheterization | Arterial Pressure | Pneumonia - mortality | Time Factors | Aged, 80 and over | Adult | Female | Heart Failure - etiology | Angioplasty, Balloon - methods | Heart Failure - mortality | Hypertension, Pulmonary - mortality | Pulmonary Embolism - complications | Reperfusion Injury - therapy | Pneumonia - etiology | Familial Primary Pulmonary Hypertension | Linear Models | Treatment Outcome | Pulmonary Artery - physiopathology | Respiration, Artificial | Pulmonary Embolism - mortality | Radiography | Pulmonary Embolism - diagnosis | Angioplasty, Balloon - mortality | Aged | Chronic Disease | Hypertension, Pulmonary - etiology | Pulmonary Embolism - physiopathology
Peripheral vascular disease | Reperfusion | Pulmonary hypertension | Revascularization | EMBOLISM | revascularization | CARDIAC & CARDIOVASCULAR SYSTEMS | pulmonary hypertension | LUNG INJURY | reperfusion | peripheral vascular disease | INTERNATIONAL PROSPECTIVE REGISTRY | ENDARTERECTOMY | Reperfusion Injury - etiology | Hypertension, Pulmonary - diagnosis | Humans | Middle Aged | Ultrasonography, Interventional | Hypertension, Pulmonary - physiopathology | Male | Pulmonary Embolism - therapy | Pulmonary Artery - diagnostic imaging | Angioplasty, Balloon - adverse effects | Hypertension, Pulmonary - therapy | Recovery of Function | Cardiac Catheterization | Arterial Pressure | Pneumonia - mortality | Time Factors | Aged, 80 and over | Adult | Female | Heart Failure - etiology | Angioplasty, Balloon - methods | Heart Failure - mortality | Hypertension, Pulmonary - mortality | Pulmonary Embolism - complications | Reperfusion Injury - therapy | Pneumonia - etiology | Familial Primary Pulmonary Hypertension | Linear Models | Treatment Outcome | Pulmonary Artery - physiopathology | Respiration, Artificial | Pulmonary Embolism - mortality | Radiography | Pulmonary Embolism - diagnosis | Angioplasty, Balloon - mortality | Aged | Chronic Disease | Hypertension, Pulmonary - etiology | Pulmonary Embolism - physiopathology
Journal Article
2011, Shohan., ISBN 4623059650, ix, 273
Book
PLoS ONE, ISSN 1932-6203, 10/2018, Volume 13, Issue 10, p. e0206054
The biomass yield (plant weight) of rice fluctuates from year to year. In a previous study, we demonstrated that six quantitative trait loci (QTLs) contribute...
GENETIC DISSECTION | ENVIRONMENT INTERACTIONS | MULTIDISCIPLINARY SCIENCES | GRAIN-YIELD | POWERFUL | TRAITS | IDENTIFICATION | WEIGHT | Quantitative trait loci | Crop yields | Growth | Physiological aspects | Genetic aspects | Research | Rice | Crop science | Fertilization | Genomics | Genomes | Biomass | Weight | Quantitative genetics | Genotype & phenotype | Agricultural production | Alleles | Inbreeding | Gene loci | Crop yield | Genotypes | Deoxyribonucleic acid--DNA | Food | Recombinant | Cultivars | Deoxyribonucleic acid | DNA
GENETIC DISSECTION | ENVIRONMENT INTERACTIONS | MULTIDISCIPLINARY SCIENCES | GRAIN-YIELD | POWERFUL | TRAITS | IDENTIFICATION | WEIGHT | Quantitative trait loci | Crop yields | Growth | Physiological aspects | Genetic aspects | Research | Rice | Crop science | Fertilization | Genomics | Genomes | Biomass | Weight | Quantitative genetics | Genotype & phenotype | Agricultural production | Alleles | Inbreeding | Gene loci | Crop yield | Genotypes | Deoxyribonucleic acid--DNA | Food | Recombinant | Cultivars | Deoxyribonucleic acid | DNA
Journal Article
2000, Minerva gendai keizaigaku sōsho, ISBN 4623032132, Volume 40, vii, 320
Book
International Journal of Clinical Oncology, ISSN 1341-9625, 12/2018, Volume 23, Issue 6, pp. 1148 - 1159
Investigating oncological outcomes in patients registered in the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) in...
External beam radiation therapy | Iodine-125 | Medicine & Public Health | Oncology | Cancer Research | Brachytherapy | Surgical Oncology | Prostate cancer | ANDROGEN SUPPRESSION | DEFINITION | BIOCHEMICAL FAILURE | ANTIGEN BOUNCE | RADIATION | ONCOLOGY | PSA KINETICS | MEN | RECTAL MORBIDITY | RADIOTHERAPY | Prostate-Specific Antigen | Multivariate Analysis | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Japan | Middle Aged | Risk Factors | Brachytherapy - methods | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Iodine Radioisotopes - therapeutic use | Survival Analysis | Aged | Research | Oncology, Experimental | Analysis | Patient outcomes | Cancer
External beam radiation therapy | Iodine-125 | Medicine & Public Health | Oncology | Cancer Research | Brachytherapy | Surgical Oncology | Prostate cancer | ANDROGEN SUPPRESSION | DEFINITION | BIOCHEMICAL FAILURE | ANTIGEN BOUNCE | RADIATION | ONCOLOGY | PSA KINETICS | MEN | RECTAL MORBIDITY | RADIOTHERAPY | Prostate-Specific Antigen | Multivariate Analysis | Prostatic Neoplasms - pathology | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Japan | Middle Aged | Risk Factors | Brachytherapy - methods | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Iodine Radioisotopes - therapeutic use | Survival Analysis | Aged | Research | Oncology, Experimental | Analysis | Patient outcomes | Cancer
Journal Article
Human Genetics, ISSN 0340-6717, 2/2016, Volume 135, Issue 2, pp. 209 - 222
RASopathies are autosomal dominant disorders caused by mutations in more than 10 known genes that regulate the RAS/MAPK pathway. Noonan syndrome (NS) is a...
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases | PROTEIN | GENE | PATHWAY | GENETICS & HEREDITY | GERMLINE MUTATIONS | PTPN11 | KRAS | OF-FUNCTION MUTATIONS | RAF1 | SOS1 | FEATURES | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | ras Proteins - genetics | Exons | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Gene Expression Regulation | SOS1 Protein - metabolism | Child, Preschool | Genetic Association Studies - methods | ras Proteins - metabolism | Infant | Male | Noonan Syndrome - genetics | Chylothorax - genetics | Pleural Effusion - genetics | Heart Defects, Congenital - genetics | Hydrops Fetalis - genetics | Nuchal Translucency Measurement | SOS1 Protein - genetics | Female | Mutation | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Infant, Newborn | Proto-Oncogene Proteins p21(ras) - metabolism | Genetic research | Genetic aspects | Congenital heart disease | Genetic disorders | Analysis | Noonan syndrome
Human Genetics | Gene Function | Molecular Medicine | Biomedicine | Metabolic Diseases | PROTEIN | GENE | PATHWAY | GENETICS & HEREDITY | GERMLINE MUTATIONS | PTPN11 | KRAS | OF-FUNCTION MUTATIONS | RAF1 | SOS1 | FEATURES | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | ras Proteins - genetics | Exons | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Gene Expression Regulation | SOS1 Protein - metabolism | Child, Preschool | Genetic Association Studies - methods | ras Proteins - metabolism | Infant | Male | Noonan Syndrome - genetics | Chylothorax - genetics | Pleural Effusion - genetics | Heart Defects, Congenital - genetics | Hydrops Fetalis - genetics | Nuchal Translucency Measurement | SOS1 Protein - genetics | Female | Mutation | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Infant, Newborn | Proto-Oncogene Proteins p21(ras) - metabolism | Genetic research | Genetic aspects | Congenital heart disease | Genetic disorders | Analysis | Noonan syndrome
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 2015, Volume 21, Issue 5, pp. 340 - 345
Abstract Worldwide, the most important concern in the treatment of sexually transmitted infections is the increase in antimicrobial resistant Neisseria...
Hematology, Oncology and Palliative Medicine | 2012 | Antimicrobial susceptibilities | Neisseria gonorrhoeae | Nationwide surveillance | Japan | 2013 | INFECTIOUS DISEASES | CEFTRIAXONE | HIGH-LEVEL RESISTANCE | AZITHROMYCIN RESISTANCE | 1ST STRAIN | MUTATION | PHARMACOLOGY & PHARMACY | Neisseria gonorrhoeae - drug effects | Humans | Middle Aged | Urethritis - microbiology | Drug Resistance, Bacterial | Ceftriaxone - pharmacology | Male | Azithromycin - pharmacology | Microbial Sensitivity Tests | Young Adult | Fluoroquinolones - pharmacology | Adolescent | Adult | Aged | Anti-Bacterial Agents - pharmacology | Cefixime - pharmacology | Penicillins - pharmacology | Population Surveillance
Hematology, Oncology and Palliative Medicine | 2012 | Antimicrobial susceptibilities | Neisseria gonorrhoeae | Nationwide surveillance | Japan | 2013 | INFECTIOUS DISEASES | CEFTRIAXONE | HIGH-LEVEL RESISTANCE | AZITHROMYCIN RESISTANCE | 1ST STRAIN | MUTATION | PHARMACOLOGY & PHARMACY | Neisseria gonorrhoeae - drug effects | Humans | Middle Aged | Urethritis - microbiology | Drug Resistance, Bacterial | Ceftriaxone - pharmacology | Male | Azithromycin - pharmacology | Microbial Sensitivity Tests | Young Adult | Fluoroquinolones - pharmacology | Adolescent | Adult | Aged | Anti-Bacterial Agents - pharmacology | Cefixime - pharmacology | Penicillins - pharmacology | Population Surveillance
Journal Article